Nachrichten zur Nordic Nanovector ASA Aktie

Radiotheranostics Market Current Trends and Future Scope Analysis Report

Companies covered in this report are TransCode Therapeutics, Inc., Curium SAS, GE Healthcare Inc., Bayer AG, Lantheus Medical, Imaging, Inc.,…

Nordic Nanovector - Appointment of Alf Bjørseth as CEO

OSLO, Norway, June 28, 2023 /PRNewswire/ -- Reference is made to the stock exchange announcement made earlier today by Nordic…

Nordic Nanovector – Appointment of Alf Bjørseth as CEO

Reference is made to the stock exchange announcement made earlier today by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company"),…

Nordic Nanovector - Completion of annual general meeting

OSLO, Norway, June 28, 2023 /PRNewswire/ -- Reference is made to the stock exchange announcement made by Nordic Nanovector ASA…

Nordic Nanovector – Completion of annual general meeting

Reference is made to the stock exchange announcement made by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") on 6…

Disclosure of proxies for the AGM

The Chairman will vote for 10.606.127 shares (or 9,14%) and the Interim CEO & CFO will vote for 20.696.277 shares…

Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023

OSLO, Norway, June 7, 2023 /PRNewswire/ -- Notice is given that the Annual General Meeting of Nordic Nanovector ASA will…

Nordic Nanovector - Mandatory notification of trade - primary insider

PRESS RELEASE   Nordic Nanovector – Mandatory Notification of trade – primary insider Oslo, Norway, 7 June 2023 Jon Magne Asmyr, the Chairman of…

Nordic Nanovector – Notice of Annual General Meeting on 28 June 2023

Notice is given that the Annual General Meeting of Nordic Nanovector ASA will be held on 28 June 2023, at…

Nordic Nanovector, Thor Medical Agree to Combine in All-Share Deal

Nordic Nanovector, Thor Medical Agree to Combine in All-Share Deal...…

Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer

Gives Nordic Nanovector access to highly promising new technology that enables the development and production of radionuclides for radioimmunoconjugate-based approaches…

Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR…

Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database

Oslo, Norway,18 April 2023 Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) announces that full results from its Phase…

NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED

OSLO, Norway, March 31, 2023 /PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA has decided to postpone the…

NORDIC NANOVECTOR – ANNUAL GENERAL MEETING POSTPONED

Oslo, Norway, 30 March 2023 The Board of Directors of Nordic Nanovector ASA has decided to postpone the upcoming Annual General…

NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED

OSLO, Norway, March 23, 2023 /PRNewswire/ -- On 22 March 2023, the Board of Directors of Nordic Nanovector ASA approved…

Nordic Nanovector ASA Results for the Second Half and Full Year 2022

OSLO, Norway, Feb. 28, 2023 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces its results…

Nordic Nanovector ASA Results for the Second Half and Full Year 2022

Oslo, Norway, 28 February 2023 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces its results for the second…

Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast

OSLO, Norway, Feb. 21, 2023 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for…

Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast

Oslo, Norway, 21 February 2023 Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the second half…

Nordic Nanovector ASA announces that Ludvik Sandnes has been appointed interim Chief Executive Officer (CEO) and Chief Financial Officer (CFO)

OSLO, Norway, Feb. 1, 2023 /PRNewswire/ -- Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") announces that Ludvik Sandnes, former…

Nordic Nanovector ASA announces that Ludvik Sandnes has been appointed interim Chief Executive Officer (CEO) and Chief Financial Officer (CFO)

Oslo, Norway, 31 January 2023 Nordic Nanovector ASA (“Nordic Nanovector” or the “Company”) announces that Ludvik Sandnes, former Chairperson of Nordic…

Nordic Nanovector board member resigns

OSLO, Norway, Jan. 19, 2023 /PRNewswire/ -- Board member Eddie Berglund has informed the board that he will resign from…

Nordic Nanovector board member resigns

Oslo, Norway, 19 January 2023 Board member Eddie Berglund has informed the board that he will resign from the board with…

Nordic Nanovector ASA Notes Publication of Letter by Largest Shareholder North Energy

Oslo, Norway, 16 January 2023 Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") notes the publication of a letter on 10…

Nordic Nanovector ASA: Extraordinary General Meeting held

OSLO, Norway, Jan. 3, 2023 /PRNewswire/ -- An Extraordinary General Meeting (the "EGM") of Nordic Nanovector ASA (the "Company") (OSE:…

Nordic Nanovector ASA: Extraordinary General Meeting held

Oslo, Norway, 3 January 2023 An Extraordinary General Meeting (the "EGM") of Nordic Nanovector ASA (the "Company") (OSE: NANOV) was held…

Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023

OSLO, Norway, Dec. 13, 2022 /PRNewswire/ -- Nordic Nanovector ASAs ("Nordic Nanovector" or the "Company") largest shareholder North Energy ASA,…

Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023

Oslo, Norway, 13 December 2022 Nordic Nanovector ASAs ("Nordic Nanovector" or the "Company") largest shareholder North Energy ASA, that now holds…

Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics

OSLO, Norway, Dec. 9, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an…

Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics

Oslo, Norway, 9 December 2022 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an update following the…

Nordic Nanovector ASA: Extraordinary General Meeting held

Oslo, Norway, 1 December 2022 An Extraordinary General Meeting (the "EGM") of Nordic Nanovector ASA (the "Company") (OSE: NANOV) was held…

Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics

OSLO, Norway, Nov. 25, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") has today launched…

Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics

Oslo, Norway, 25 November 2022 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") has today launched a new dedicated…

Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics

OSLO, Norway, Nov. 23, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") will host a…

Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics

Oslo, Norway, 23 November 2022 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") will host a webcast, including a…

Nordic Nanovector comment on Proposed Merger with APIM Therapeutics

OSLO, Norway, Nov. 21, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") desires to share…

Nordic Nanovector comment on Proposed Merger with APIM Therapeutics

Oslo, Norway, 21 November 2022 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") desires to share more information with…

Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022

OSLO, Norway, Nov. 10, 2022 /PRNewswire/ -- Reference is made to the stock exchange announcement by Nordic Nanovector ASA ("Nordic…

Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022

Oslo, Norway, 10 November 2022 Reference is made to the stock exchange announcement by Nordic Nanovector ASA ("Nordic Nanovector" or the…

Nordic Nanovector and APIM Therapeutics Announce Merger Agreement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR…

Nordic Nanovector and APIM Therapeutics Announce Merger Agreement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR…

Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting

OSLO, Norway, Nov. 3, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces the progress…

Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting

Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting Oslo,…